Tango Therapeutics
TNGX
21.73
-0.98
-4.32%
Tango Therapeutics
US · TNGX
#2322 by market cap
Listed 1970
21.73
-0.98
-4.32%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:41
Quant vs Street three independent views, side by side
StockVane factor grade
B+
Momentum strategy signal
Sell
Analyst consensus
Buy
Mostly aligned, one view stands apart.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
✦ Quant Analyst Revision Trend how this is computed
Mixed
1
■ Upgrades■ Downgrades
- 1 upgrade vs 0 downgrades among tracked analyst rating changes.
- Most recent: Jefferies moved from Hold to Buy on 2026-06-25.
Analyst consensus 6 analysts
Buy
Avg price target 48.67 +124.0%
Price target rangecurrent 21.73
Low35.00
Avg48.67
High67.00
Buy 100%
Hold 0%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-11-10 | CCORF | -- | Buy | 46.00 |
| 2026-11-10 | H.C. Wainwright | -- | Buy | 67.00 |
| 2026-11-10 | J.P. Morgan | -- | Buy | 47.00 |
| 2026-11-09 | Guggenheim | -- | Buy | 35.00 |
| 2026-11-09 | J.P. Morgan | -- | Buy | 47.00 |
| 2026-10-29 | H.C. Wainwright | -- | Buy | 68.00 |
| 2026-10-23 | CCORF | -- | Buy | 46.00 |
| 2026-10-23 | Stifel | -- | Buy | 55.00 |
| 2026-10-23 | J.P. Morgan | -- | Buy | -- |
| 2026-10-15 | William Blair | -- | Buy | 42.00 |
| 2026-10-13 | J.P. Morgan | -- | Buy | -- |
| 2026-10-12 | CCORF | -- | Buy | 46.00 |
| 2026-10-08 | CCORF | -- | Buy | 46.00 |
| 2026-09-24 | CCORF | -- | Buy | 46.00 |
| 2026-09-24 | Guggenheim | -- | Buy | 35.00 |
| 2026-09-11 | CCORF | -- | Buy | 46.00 |
| 2026-08-18 | H.C. Wainwright | -- | Buy | 68.00 |
| 2026-08-17 | Stifel | -- | Buy | 40.00 |
| 2026-08-12 | CCORF | -- | Buy | 46.00 |
| 2026-08-12 | Wedbush | -- | Buy | 39.00 |
| 2026-08-11 | CCORF | -- | Buy | 46.00 |
| 2026-08-11 | Guggenheim | -- | Buy | 35.00 |
| 2026-08-06 | CCORF | -- | Buy | 46.00 |
| 2026-07-30 | CCORF | -- | Buy | 46.00 |
| 2026-07-23 | CCORF | -- | Buy | 46.00 |
Price target trend monthly average, last 3 years
Recent rating changes
| Date | Firm | Change | Target |
|---|---|---|---|
| 2026-06-25 | Jefferies | Hold → Buy | 60.00 |
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2025/Q4 | 2026-03-05 | -- | -- | +36.28% |
| 2025/Q3 | 2025-11-04 | -- | ±18.41% | +0.00% (in line) |
| 2025/Q2 | 2025-08-05 | -- | ±42.88% | +4.86% (in line) |
| 2025/Q1 | 2025-05-12 | -- | -- | +14.91% |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-11-20 19:41:45 · For reference only, not investment advice and not tailored to your situation.
Tango Therapeutics discussion 0 comments